The Supreme Court ruled that a knockoff version of Amarin’s Vascepa didn’t infringe on patents — a decision with far-reaching ...
By Blake Brittain WASHINGTON, June 4 (Reuters) - Drugmaker Hikma's generic version of Amarin Pharma's cardiovascular ...
Among the three opinions arriving on Thursday from the April argument session was Hikma Pharmaceuticals USA v. Amarin Pharma.
The Supreme Court rules 9–0 in a case led by Justice Jackson, shaping how patent law applies to generic drug “skinny labels.” ...
Canada is the first G7 country to approve the lower cost weight-loss drugs, which are rolling out in pharmacies this month.
The Supreme Court unanimously ruled that Hikma Pharmaceutical did not infringe patents held by Amarin in a decision with ...
The Supreme Court said a district court judge was right to dismiss Amarin Pharma Inc.'s infringement suit over claims its ...
In April, Dr. Reddy’s Laboratories Ltd. became the first drug maker approved by Health Canada to sell a generic version of ...
India got it earlier this year, and Canada approved it last month. But when is the United States going to get a generic version of Ozempic?
The big unknown is whether CDMO capacity built for branded drugs gets diverted to generics, and whether SPPS can scale fast ...
In a unanimous ruling, Justice Jackson said drugmakers weren’t violating the law by truthfully describing a generic drug as ...
President Donald Trump announced Monday that more than 600 generic medications are being added to the government-backed discount website TrumpRx, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results